Dr. Steven Narod is a world-leader in the field of breast and ovarian cancer. Over the course of his career, he has profoundly shaped current knowledge of how to assess breast and ovarian cancer risk and reduce its mortality amongst carriers of BRCA1 and BRCA2 mutations. He studies various aspects of cancer genetics, including prevention, screening and treatment. Dr. Narod has identified founder mutations in a number of ethnic populations, including people of French-Canadian, Bahamian and Ashkenazi Jewish descent. His database of over 18,000 women with mutations from 20 countries supports numerous international collaborations. He had has a leadership role in cancer genetics studies in North America, Asia, Europe, the Caribbean and Latin America. Of particular importance was documenting the role of preventive oophorectomy on reducing death from breast and ovarian cancer. His current studies focus on chemoprevention and MRI surveillance as an alternative to preventive surgeries as a means of reducing breast cancer risk and mortality. In other areas, he directs a Canada-wide research program in the study of breast cancer in young women. He also studies the early stages of breast cancer, including DCIS and the natural history and treatment of ovarian cancer. With more than 800 peer-reviewed publications and an h-index of 100, Dr. Narod is one of the most highly cited cancer researchers in the world.
MD, University of British Columbia, 1979